What is the Forecast Price for Pfizer Inc. (PFE) Stock?

Thursday, August 13, 2020 2:51 PM | InvestorsObserver Analysts

Analysts who follow Pfizer Inc. (PFE) on average expect it to add 9.50% over the next twelve months. Those same analysts give the stock an average rating of Buy.

That average rating earns PFE an Analyst Ranking of 34, which means it ranks higher than 34 of stocks, based on data compiled by InvestorsObserver.

Overall Score - 3.8
Wall Street analysts are rating PFE a Buy today. Find out what this means to you and get the rest of the rankings on PFE!

Why are Analyst Ratings Important?

Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.

Investors Observer combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.

What's Happening With Pfizer Inc. Stock Today?

Pfizer Inc. (PFE) stock is down -0.89% while the S&P 500 has risen 0.05% as of 2:35 PM on Thursday, Aug 13. PFE is down -$0.34 from the previous closing price of $38.33 on volume of 8,740,904 shares. Over the past year the S&P 500 is higher by 19.06% while PFE has risen 10.95%. PFE earned $2.52 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 15.13.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like

Related Articles

Lexicon Pharmaceuticals, Inc. (LXRX) Stock: Buy, Hold, or Sell?

Is Aerpio Pharmaceuticals Inc (ARPO) Stock a Smart Investment?

OpGen Inc (OPGN) Stock Increases 1.86% This Week; Should You Buy?

Pulmatrix Inc (PULM) Stock: Buy, Hold, or Sell?

Do Analysts Expect Mesoblast limited (MESO) Stock to Rise?

Related Companies